Clinicopathological Differences in HER2 Immunohistochemical Expression Between Low-Grade Endometrial Cancer with p53-Abnormal Expression and High-Grade Endometrial Cancer. [PDF]
Cancers (Basel)Hachisuga K +11 more
europepmc +1 more source
FKBP52 dictates the dual role of p53 in hepatocellular carcinoma: Mutation-specific prognostic stratification and therapeutic implications. [PDF]
J Biol ChemWu J +7 more
europepmc +1 more source
Related searches:
Arsenic Trioxide Rescues Structural p53 Mutations through a Cryptic Allosteric Site
Cancer Cell, 2021Min Lu, Xin Lu, Shuo Chen
exaly
Mutant p53 suppresses innate immune signaling to promote tumorigenesis
Cancer Cell, 2021Tomoo Iwakuma +2 more
exaly
p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR)
Cell, 2021Michael C Bassik +2 more
exaly
Targeting p53 for the treatment of cancer
Seminars in Cancer Biology, 2022Naoise Synnott +2 more
exaly
Altered RNA Splicing by Mutant p53 Activates Oncogenic RAS Signaling in Pancreatic Cancer
Cancer Cell, 2020Luisa F Escobar-Hoyos +2 more
exaly
A p53 Super-tumor Suppressor Reveals a Tumor Suppressive p53-Ptpn14-Yap Axis in Pancreatic Cancer
Cancer Cell, 2017Seung K. Kim, Nitin Raj, Jacob McClendon
exaly
p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression
Cell, 2019Allison Mayle +2 more
exaly